These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
493 related items for PubMed ID: 10538456
1. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy. Ettinger B, Pressman A. Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456 [Abstract] [Full Text] [Related]
2. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen. Ettinger B, Pressman A, Bradley C. Menopause; 1998 Jun; 5(3):152-6. PubMed ID: 9774760 [Abstract] [Full Text] [Related]
8. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance. Erenus M, Karakoç B, Gürler A. Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947 [Abstract] [Full Text] [Related]
9. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women. Kurtay G, Ozmen B, Erguder I. Maturitas; 2006 Jan 10; 53(1):32-8. PubMed ID: 16325022 [Abstract] [Full Text] [Related]
10. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate. Castelo-Branco C, Casals E, Sanllehy C, Duran M, Fortuny A, Vanrell JA. J Reprod Med; 1996 Nov 10; 41(11):833-8. PubMed ID: 8951134 [Abstract] [Full Text] [Related]
11. Differential effects of oral conjugated equine estrogen and transdermal estrogen on atherosclerotic vascular disease risk markers and endothelial function in healthy postmenopausal women. Ho JY, Chen MJ, Sheu WH, Yi YC, Tsai AC, Guu HF, Ho ES. Hum Reprod; 2006 Oct 10; 21(10):2715-20. PubMed ID: 16807281 [Abstract] [Full Text] [Related]
12. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels. Chiantera V, Sarti CD, Fornaro F, Farzati A, De Franciscis P, Sepe E, Borrelli AL, Colacurci N. Menopause; 2003 Oct 10; 10(4):286-91. PubMed ID: 12851511 [Abstract] [Full Text] [Related]
14. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens]. Winkler UH, Krämer R, Kwee B, Schindler AE. Zentralbl Gynakol; 1995 Oct 10; 117(10):540-8. PubMed ID: 7491837 [Abstract] [Full Text] [Related]
16. Hormone replacement therapy use and variations in the risk of breast cancer. Opatrny L, Dell'Aniello S, Assouline S, Suissa S. BJOG; 2008 Jan 10; 115(2):169-75; discussion 175. PubMed ID: 18081598 [Abstract] [Full Text] [Related]
17. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus. Araújo DA, Farias ML, Andrade AT. Climacteric; 2002 Sep 10; 5(3):286-92. PubMed ID: 12419087 [Abstract] [Full Text] [Related]
18. Hormone replacement therapy and breast density changes. Harvey J, Scheurer C, Kawakami FT, Quebe-Fehling E, de Palacios PI, Ragavan VV. Climacteric; 2005 Jun 10; 8(2):185-92. PubMed ID: 16096175 [Abstract] [Full Text] [Related]
19. Hormone replacement therapy and cancer. Gynecol Endocrinol; 2001 Dec 10; 15(6):453-65. PubMed ID: 11826770 [Abstract] [Full Text] [Related]
20. Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women. Xia X, Zhang S, Yu Y, Zhao N, Liu R, Liu K, Chen X. J Reprod Immunol; 2009 Jul 10; 81(1):89-96. PubMed ID: 19497624 [Abstract] [Full Text] [Related] Page: [Next] [New Search]